375 related articles for article (PubMed ID: 7827049)
1. Reduction of chromium(VI) by ascorbate leads to chromium-DNA binding and DNA strand breaks in vitro.
Stearns DM; Kennedy LJ; Courtney KD; Giangrande PH; Phieffer LS; Wetterhahn KE
Biochemistry; 1995 Jan; 34(3):910-9. PubMed ID: 7827049
[TBL] [Abstract][Full Text] [Related]
2. Chromium(VI) reduction by ascorbate: role of reactive intermediates in DNA damage in vitro.
Stearns DM; Courtney KD; Giangrande PH; Phieffer LS; Wetterhahn KE
Environ Health Perspect; 1994 Sep; 102 Suppl 3(Suppl 3):21-5. PubMed ID: 7843100
[TBL] [Abstract][Full Text] [Related]
3. Reaction of chromium(VI) with ascorbate produces chromium(V), chromium(IV), and carbon-based radicals.
Stearns DM; Wetterhahn KE
Chem Res Toxicol; 1994; 7(2):219-30. PubMed ID: 8199312
[TBL] [Abstract][Full Text] [Related]
4. Formation of reactive oxygen species and DNA strand breakage during interaction of chromium (III) and hydrogen peroxide in vitro: evidence for a chromium (III)-mediated Fenton-like reaction.
Tsou TC; Yang JL
Chem Biol Interact; 1996 Dec; 102(3):133-53. PubMed ID: 9021167
[TBL] [Abstract][Full Text] [Related]
5. Intermediates produced in the reaction of chromium(VI) with dehydroascorbate cause single-strand breaks in plasmid DNA.
Stearns DM; Wetterhahn KE
Chem Res Toxicol; 1997 Mar; 10(3):271-8. PubMed ID: 9084906
[TBL] [Abstract][Full Text] [Related]
6. Effects of mannitol or catalase on the generation of reactive oxygen species leading to DNA damage by Chromium(VI) reduction with ascorbate.
Tsou TC; Lai HJ; Yang JL
Chem Res Toxicol; 1999 Oct; 12(10):1002-9. PubMed ID: 10525278
[TBL] [Abstract][Full Text] [Related]
7. Lower mutagenicity but higher stability of Cr-DNA adducts formed during gradual chromate activation with ascorbate.
Quievryn G; Messer J; Zhitkovich A
Carcinogenesis; 2006 Nov; 27(11):2316-21. PubMed ID: 16714765
[TBL] [Abstract][Full Text] [Related]
8. Genotoxicity and mutagenicity of chromium(VI)/ascorbate-generated DNA adducts in human and bacterial cells.
Quievryn G; Peterson E; Messer J; Zhitkovich A
Biochemistry; 2003 Feb; 42(4):1062-70. PubMed ID: 12549927
[TBL] [Abstract][Full Text] [Related]
9. Carcinogenic chromium(VI) induces cross-linking of vitamin C to DNA in vitro and in human lung A549 cells.
Quievryn G; Messer J; Zhitkovich A
Biochemistry; 2002 Mar; 41(9):3156-67. PubMed ID: 11863455
[TBL] [Abstract][Full Text] [Related]
10. Reductive metabolism of Cr(VI) by cysteine leads to the formation of binary and ternary Cr--DNA adducts in the absence of oxidative DNA damage.
Zhitkovich A; Shrager S; Messer J
Chem Res Toxicol; 2000 Nov; 13(11):1114-24. PubMed ID: 11087433
[TBL] [Abstract][Full Text] [Related]
11. Role of chromium(IV) in the chromium(VI)-related free radical formation, dG hydroxylation, and DNA damage.
Luo H; Lu Y; Mao Y; Shi X; Dalal NS
J Inorg Biochem; 1996 Oct; 64(1):25-35. PubMed ID: 8837499
[TBL] [Abstract][Full Text] [Related]
12. Critical role of chromium (Cr)-DNA interactions in the formation of Cr-induced polymerase arresting lesions.
O'Brien T; Mandel HG; Pritchard DE; Patierno SR
Biochemistry; 2002 Oct; 41(41):12529-37. PubMed ID: 12369844
[TBL] [Abstract][Full Text] [Related]
13. Production of activated species of oxygen during the chromate(VI)-ascorbate reaction: implication in carcinogenesis.
Lefebvre Y; Pézerat H
Chem Res Toxicol; 1992; 5(4):461-3. PubMed ID: 1327248
[TBL] [Abstract][Full Text] [Related]
14. In vivo effects of ascorbate and glutathione on the uptake of chromium, formation of chromium(V), chromium-DNA binding and 8-hydroxy-2'-deoxyguanosine in liver and kidney of osteogenic disorder shionogi rats following treatment with chromium(VI).
Yuann JM; Liu KJ; Hamilton JW; Wetterhahn KE
Carcinogenesis; 1999 Jul; 20(7):1267-75. PubMed ID: 10383900
[TBL] [Abstract][Full Text] [Related]
15. Cr(IV) causes activation of nuclear transcription factor-kappa B, DNA strand breaks and dG hydroxylation via free radical reactions.
Shi X; Ding M; Ye J; Wang S; Leonard SS; Zang L; Castranova V; Vallyathan V; Chiu A; Dalal N; Liu K
J Inorg Biochem; 1999 May; 75(1):37-44. PubMed ID: 10402675
[TBL] [Abstract][Full Text] [Related]
16. Chromium(VI) causes interstrand DNA cross-linking in vitro but shows no hypersensitivity in cross-link repair-deficient human cells.
Morse JL; Luczak MW; Zhitkovich A
Chem Res Toxicol; 2013 Oct; 26(10):1591-8. PubMed ID: 24059640
[TBL] [Abstract][Full Text] [Related]
17. Reaction of Cr(VI) with ascorbate and hydrogen peroxide generates hydroxyl radicals and causes DNA damage: role of a Cr(IV)-mediated Fenton-like reaction.
Shi X; Mao Y; Knapton AD; Ding M; Rojanasakul Y; Gannett PM; Dalal N; Liu K
Carcinogenesis; 1994 Nov; 15(11):2475-8. PubMed ID: 7955094
[TBL] [Abstract][Full Text] [Related]
18. Reductive activation with cysteine represents a chromium(III)-dependent pathway in the induction of genotoxicity by carcinogenic chromium(VI).
Zhitkovich A; Quievryn G; Messer J; Motylevich Z
Environ Health Perspect; 2002 Oct; 110 Suppl 5(Suppl 5):729-31. PubMed ID: 12426121
[TBL] [Abstract][Full Text] [Related]
19. Two pathways for chromium(VI)-induced DNA damage in 14 day chick embryos: Cr-DNA binding in liver and 8-oxo-2'-deoxyguanosine in red blood cells.
Misra M; Alcedo JA; Wetterhahn KE
Carcinogenesis; 1994 Dec; 15(12):2911-7. PubMed ID: 8001255
[TBL] [Abstract][Full Text] [Related]
20. Ascorbate is the principal reductant of chromium(VI) in rat lung ultrafiltrates and cytosols, and mediates chromium-DNA binding in vitro.
Standeven AM; Wetterhahn KE
Carcinogenesis; 1992 Aug; 13(8):1319-24. PubMed ID: 1499083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
